GSK’s Bet On Spero’s Oral cUTI Antibiotic Poised To Pay Off With New Phase III Data

 
• By Joseph Haas
  
Spero, GSK may bring first oral antibiotic to cUTI patients (Shutterstock)

More from Strategy

More from Therapy Areas